Evaluation of two fungal exopolysaccharides as potential biomaterials for wound healing applications

Masoud Hamidi1,2, Oseweuba Valentine Okoro1, Khodabakhsh Rashidi3

  • 1Université Libre de Bruxelles (ULB), École Polytechnique de Bruxelles, 3BIO-BioMatter, Avenue F.D. Roosevelt, 50 - CP 165/61, 1050, Brussels, Belgium.

Insights

Microbial exopolysaccharides (EPSs) from fungus and yeast show promise for biomedical applications. These EPSs demonstrated biocompatibility and enhanced wound healing in vivo, suggesting potential for dermal applications.

Area of Science:

  • Microbiology and Biotechnology
  • Biomaterials Science

Background:

  • Microbial exopolysaccharides (EPSs) are versatile biopolymers with potential biomedical applications.
  • Fungal and yeast-derived EPSs are increasingly explored for their unique properties.

Purpose of the Study:

  • To investigate the in vitro biological activities and in vivo wound healing effects of EPSs from Sclerotium glucanicum and Rhodosporidium babjevae.
  • To characterize the physicochemical and biological properties of scleroglucan (Scl) and EPS-R.

Main Methods:

  • EPSs were extracted from Sclerotium glucanicum and Rhodosporidium babjevae.
  • Physicochemical properties were analyzed using infrared spectroscopy and scanning electron microscopy.
  • In vitro cytocompatibility and hemocompatibility were assessed, alongside in vivo wound healing tests.

Main Results:

  • EPS yields of 0.9 g/L and 1.11 g/L were obtained, respectively.
  • Both EPSs exhibited cytocompatibility with human fibroblasts and hemocompatibility.
  • Significant wound healing capacities were observed in vivo at 10 mg/mL concentration.

Conclusions:

  • EPSs from S. glucanicum and R. babjevae are biocompatible.
  • These microbial EPSs show potential for promoting dermal wound healing.
  • Further research into these EPSs could lead to novel biomaterials for regenerative medicine.